Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.

Ophthalmology Times, hosted by Douglas D. Koch, MD, Professor and Allen, Mosbacher, and Law Chair in Ophthalmology at the ...

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...

Celebrating 75 years of intraocular lens advancements that have improved care for millions of cataract patients. On November 29, 1949, Sir Harold Ridley performed a surgical procedure to replace a ...

MESA, AZ - February 17, 2026 - PRESSADVANTAGE - Carrot LASIK & Eye Center has released a detailed overview titled ...

Cataract surgery is a once-in-a-lifetime investment in your eyes that can improve your quality of life for the long term. Advanced lens options can reduce or eliminate the need for glasses after your ...

Verified Market Research® indicates that the Global Intraocular Lens Market was valued at USD 4.46 Billion in 2024 and is projected to reach USD 6.53 Billion by 2032, expanding at a CAGR of 5.38% ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Five eyes of five patients underwent phakonit with ...

Germany-headquartered Carl Zeiss Meditec has acquired the US firm Aaren Scientific Inc., a manufacturer of intraocular lenses (IOLs) used after cataract surgeries, for an undisclosed sum. The Ontario, ...